ZENITHDRUG — Zenith Drugs Balance Sheet
0.000.00%
- IN₹977.48m
- IN₹1.46bn
- IN₹1.33bn
- 21
- 68
- 25
- 28
Annual balance sheet for Zenith Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PRESS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 30 | 36.1 | 87.4 | 2.63 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 384 | 566 | 753 | 726 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 535 | 839 | 1,128 | 1,152 |
| Net Property, Plant And Equipment | 131 | 117 | 148 | 432 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 686 | 979 | 1,342 | 1,615 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 466 | 718 | 641 | 793 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 565 | 807 | 720 | 921 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 121 | 172 | 622 | 694 |
| Total Liabilities & Shareholders' Equity | 686 | 979 | 1,342 | 1,615 |
| Total Common Shares Outstanding |